DIFLUPREDNATE 0.05%w/v IP + MOXIFLOXACIN 0.5%w/v IP + SORBIC ACID 0.1%w/v IP

An ophthalmic formulation of antibiotic/corticosteroid for the prevention of infection and control of inflammation associated with ocular surgery. An anti-infective broad-spectrum bactericidal drug against common ocular pathogens, and relieves inflammation. Lowers certain chemicals that cause itching, redness, swelling, or pain in the eye. A valuable therapeutic agent for the treatment of ocular inflammation. An ideal topical corticosteroid preparation with excellent anti-inflammatory properties. (Donnenfeld, 2011) A convenient and effective approach to managing postoperative ocular inflammation. (Stephen Smith, 2010) Exerts potent and rapid bactericidal activity against the most common gram-positive postoperative endophthalmitis pathogens. (Terrence P O'Brien, 2007) Has high potency against a broad range of microbial species and a favorable profile in terms of safety and tolerability. (Eduardo Alfonso, 2005) Clears postoperative inflammation and reduces pain rapidly and effectively. (Michael S Korenfeld, 2009) A suitable medicament to manage inflammatory conditions and pain after cataract surgery. (Rajashree Reddy, 2018) Prevents inflammation by inhibiting the release of inflammatory mediators and relieves symptoms such as pain, redness, and swelling. (Mahmoud Tawfik KhalafAllah, 2019)